Johnson & Johnson
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 55.85 |
| 52 Week High | 72.76 |
| 52 Week Low | 52.06 |
| Avg. Daily Vol. (Mil) | 16.07 |
| Beta (3 year) | 0.39 |
| Share Related Items | |
| Mkt Cap (Mil) | 156,072.58 |
| Shares Out (Mil) | 2,794.50 |
| Float (Mil) | 2,793.50 |
| Dividend Information | |
| Yield % | 3.30 |
| Annual Dividend | 1.84 |
| Payout Ratio | 42.00 |
| Financial Strength | |
| Quick Ratio | 1.10 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.19 |
| Total Debt / Equity | 0.30 |
| Valuation Ratios | |
| Price Earnings | 13.50 |
| Price/Sales | 2.45 |
| Price/Book | 3.36 |
| Price/Cash Flow | 10.60 |
| Per Share Data | |
| Earnings | 4.13 |
| Sales | 22.75 |
| Book Value | 16.62 |
| Cash Flow | 5.25 |
| Business Summary | |
|---|---|
| A holding company, which is engaged in research and development, manufacture and sale of products in the health care field. It focuses on products related to human health and well-being. | |
| General Information | |
| One Johnson & Johnson Plaza
New Brunswick, NJ 08933 |
|
| www.jnj.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 119200 | |
| CEO: William C. Weldon | |
| Short Interest | |
| Current Month (Mil) | 26.48 |
| Previous Month (Mil) | 26.45 |
| Short Interest Ratio (Days) | 2.20 |
| Management Effectiveness | |
| Return on Equity | 25.50 |
| Return on Assets | 13.40 |
| Return on Investments | 21.50 |
| Profitability | |
| Gross Margin | 75.50 |
| EBIT Margin | 23.80 |
| Profit Margin | 18.60 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas